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Methods: DNA extracted from explanted DCM hearts (n=l7, 1 female; 49+/-13 years; 
LVEF: la+/-5%) were investigated for clonality of the TCR-P-gene. Non-DCM-hearts 
(ischaemic cardiomyopathy: n=2, valvular heart disease: n=3, donor hearts: n=3) served 
as Cantrob. The TCR-PCR-products analyzed by high-resolution fragment analysis 
(GeneScan), displayed a Gaussian-like distribution profiles I” polyclonal and single dom- 
inant peaks ln monoclonal T-cell populations. Clonal TCR-P PCR-products were directly 
sequenced. 
Results: The GeneScan analysis of the TCR-P PCR-products demonstrated a clonal T- 
cell population in n=9117 (53%) of the DCM hearts. In contrast, exclusively polyclonal 
composition of the TCR-P PCR-products were obtained from the non-DCM hearts. 
Sequence analysis of the clonal TCR-P PCR-products from the n=9 DCM hearts deter- 
mined Vpl9.01 in n=6 cases (67%), and VP-1 .Ol, Vp6-3.01 and VplO-3.04 in each of 
the remaining cases. 
Conclusion: Clonal T-cell composition is exclusively present in DCM, as detected by 
PCR and GeneScan analysis of the TCR-P rearrangement. This phenomenon indicates a 
clonal T-cell proliferation due to specific antigen, which confirms the autoimmune hypoth- 
esis of DCM. Our results, demonstrating a clear predominance of Vpl9.01 T-cell clones 
in DCM, warrant the molecular analysis of the respective immunogenic sequence and 
eventually a TCR-based immunotherapy in DCM (e.g. with DNA vaccines). 
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Background: Opiod Growth Factor (OGF) is an Inhibitory pentapeptide that interacts 
with its receptor (OGFr) to target cell proliferabon and DNA synthesis. Previous studies 
have shown that chrome disruption of the OGF/OGFr interaction by naltrexone (NTX) 
had a stimulatory effect on myocardial development. We hypothesized that in utero expo- 
sure to NTX alters postnatal cardiac function. 
Methods: Time-mated Sprague-Da&y rats received injections of 30 mglkg of NTX or 
0.3 ml saline twice a day throughout gestation. Offspring wets cross-fostered to non- 
injected, lactating females. Left ventricle (LV) size and function were evaluated by 
echocardiography in postnatal day (PD) 35, 55 and 110 NTX exposed and control rats. 
Six to eight male and female offspring of each group were studied for LV end diastolic 
dimension, LV thickness, shortening fraction (SF) and heart rate. 
Results: PD 35 male and female and PD55 female offspring exposed to NTX had signif- 
icantly dilated left ventricles compared to controls (p<O.Ol). PDllO NTX exposed rats 
had increased thickness of the LV free wall (pcO.O5), but no changes occurred earlier. SF 
was significantly decreased (p.zO.01) relative to controls in all NTX exposed rats at all 
ages studied. SF decreases in the NTX group ranged from 12-19%. Heart rate was sig- 
nificantly decreased in the NTX exposed rats compared to controls (~~0.05). 
Conclusions: NTX exposed offspring demonstrated significant changes in ventricular 
size, systolic function and heart rate. The NTX exposed rats had dilated left ventricles at 
earlier ages .The NTX rats had decreased ventricular systolic function and decreased 
heari rates at all ages studied. This data suggests that in utero blockade of OGF activity 
by NTX leads to significant ventricular dilation and impared systolic function. This infor- 
mation may provide a unique model that will allow for further study of dilated cardiomyo- 
pathies. 
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Background: In chronic heart failure (CHF), periodic oscillations in 0, consumption 
(Vq). CO, production (VCOJ and ventilation may appear in the Initial phases of car- 
diopulmonary exercise test, with controversial clinical significance. AIM: To characterize, 
in clinical and functional terms, CHF patients with an oscillatory gas kinetics during car- 
diopulmonary test. Methods: We evaluated 195 clinically stable CHF outpatients (171 
males; mean age 62.3+9 years), with an echocardiogram and a cardiopulmonary, symp- 
tom-limited, exercise test. Results: Twenty-SIX patients had an oscillatory pattern of VQ 
and VCO, in the initial phases of exercise (group 1). while 169 did not (group 2). Mean 
age was 67.1*6.5 years in group 1 and 61.5k8.9 in group 2 (p=O.O03). Ejection fraction 
(EF) was 29+8% versus 34+7% respectively (p=O.O09). NO differences existed in sex. 
etiology, NYHA class, cardiac rhythm and mean peak respiratory quotient (>I .I 1 in both 
groups). Patients with an oscillatory pattern had a significantly lower peak VO, (13.2+3.4 
mUKg/mm versus 16.8*4.8; p=O.O003). a higher ventilatory equivalent response (VEI 
VC0$.lope)(4l.O+6.2 versus 36.226.1, respectively; p=O.O003), a shorter exercise dura- 
tion time (7.8+2.0 minutes versus 9.6e2.4; p=O.O004) and a lower peak systolic blood 
pressure (158.1*23.6 mmHg versus 176.9i31.8; p=O.O04). At univariate analysis, peak 
VO? correlated with age, sex, NYHA class, EF, peak systolic blood pressure and oscilla- 
toly pattern. In a multivariate analysis model comprising all the univariate determinants of 
peak Vq, the oscillatory kinetics predicted peak VO, independently of the other vari- 
ables (p=O.OOS). At univ.&ate analysis, VE/VCO$lope correlated with age, sex, NYHA 
class, EF, peak systolic blood pressure and oscillatory pattern. In a multivariate model 
analyzing the VENCO,slope and all these covariates, the oscillatory kinetics was an 
independent predictor of the ventilatory equivalent response (p=O.O17). Conclusions In 
CHF, an oscillatory pattern of respiratory gas exchange during cardiopulmonary test is 
associated with a significantly warse exercise tolerance, independently of other known 
determinants of functional capacity 
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Background: Endothelin-1 (ET-l) receptor antagonist is expected to improve prognosis 
of patients with heart failure, but the effect of ETA and ETB receptor antagonist on car- 
diac function and structure is still controversial. We assessed the hypothesis that long- 
term treatment with ETA receptor antagonist could reduce inducible nitric oxide synthase 
(INOS) in failing heart and improve the cardiac dysfunction in the model of dilated cardi- 
omyopathy. Methods: A selective ETA receptor antagonist ABT-627 (ETa; 10 mgikglday) 
or a selective ETB receptor antagonist A-192621 (ETb: 15 mglk g/day) was given in 22- 
week-old J-2-N cardiomyopathic (Nk) hamsters, representing severe heart failure, for 2 
months. ET-l content and NADPH diaphorase activity in left ventricular (LV) myocardium 
were studled by electron microscopy. Results: Though ETb showed inotropic and chro- 
notropic effect on cardiac function, degeneration of cardiomyocytes remarkably pro- 
gressed. ETa efficiently preserved the LV diastolic function and tissue damage, 
furthermore suppressed the NADPH diaphorase activity representing iNOS and ET-1 
content in LV. Conclusions: Both ETa and ETb are potent to improve cardiac function. 
However, only ETa could reduce iNOS and ET-1 content, and also preserve the fine 
structure of LV myocardium in cardiomyopathy. 
Control Nk+vehicle Nk+ETa Nk+ETb 
(n=10) (ll=lO) (n=9) (ll=lO) 
Heart Rate (bpm) 392*9 364+18 367+20 458+9^# 
LV pressure (mmHg) 152~7 109*3* 103+3 130*2’# 
Ejection Fraction (%) 40+4 22*1* 24+2 35+3?# 
Dct (cm/s?) 1425*108 2517*190* 1886+105# 1908+178# 
Cardiac@ Diameter 17.8ztO.l 26.1+0.6’ 18.5+0.5# 27.3kO.7’ 
(urn) 
Values are Mean&EM. Dct; deceleration slope. *pcO.O5 Versus Control. #p,O.O5 
Versus Nk+vehicle. 
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Background Idiopathic dilated cardiomyopathy (DCM) is familial in up to 30% of cases. 
Recent studies have shown that mutations in the lamin A!C (LMNA) gene can cause 
dilated cardiomyopathy with or without preceding cardiac conduction disease (CCD). 
Mutations in this gene are identified in up to 33% of cases with DCM+CCD. Our purpose 
was to assess to what extent mutations in the LMNA gene are responsible for DCM ci- 
CCD in our population and to test the hypothesis that LMNA mutations can be identified 
in patients with (still) pure CCD because CCD can precede DCM by 10 to 20 years. 
Methods we studied the LMNA gene in 27 index cases with a cardiac phenotype but with- 
out overt signs of generalised myopathy using a PCRlDGGEisequencing analysis. 10 
Index patients had DCM+CCD, 14 had “pure” DCM, 3 had CCD. Patients were subclassi- 
fied according to family history and additional medical information from family members 
(see table). 
Results (see table)Novel mutations were identified in 1 family with pure DCM (1512. 
1513insAG) and in a patient with DCM+CCD and a positive family history (IVS7+1 G>A). 
Mutations described before were identified in 1 large family with DCM+CCD (AsnlSbLys) 
and 1 family with CCD (Arg225X). 
Conclusions LMNA mutations were identified in families with DCM +CCD or pure DCM 
but also in a family with isolated CCD. LMNA mutations can be identified in patients or 
families with (still) an isolated CCD phenotype because CCD can precede DCM by up to 
20 years. Two of the mutations identified were not described before. 
phenotype/total no category no. patients mutation 
DCM+CCD (n=lO) proven familial 5 Asnl95Lys 
pas. family history 2 IVS7+lG>A(novel) 
sporadic 3 
pure DCM (n=l4) proven familial 11 1512.1513insAG(novel) 
pas. family history 1 
sporadic 2 
CCD (n=3) familial 3 Arg225X 
total 27 4 
